Skip to main content
. 2019 Aug 2;11(8):385. doi: 10.3390/pharmaceutics11080385

Scheme 1.

Scheme 1

Schematic representation of the approach to overcome multi-drug resistance (MDR) in breast cancer by a co-delivery of resvertrol (Res) and doxorubicin (Dox) with methoxy poly (ethylene glycol)-poly(d,l-lactide)-poly(l-histidine) (mPEG-PLA-PHis).